DART 3: A pragmatic stepped wedge cluster randomised trial of ultrasound guidance to reducing multiple PIVC insertions in hospitalised patients
Jessica Schults1,2,3,4,6, Nicole Marsh2,3,4, Amanda Ullman2,3,4,5,6, Tricia Kleidon2,3,4,5, Robert Ware7, Joshua Byrnes7,8, Emily Young7, Lisa Hall1,9, Gerben Keijzers7,10,11, Louise Cullen12, Pauline Calleja4,13, Steven McTaggart5,6, Nathan Peters14,15, Stuart Watkins10, Amanda Corley2,3,4, Christine Brown2, Zhen, Lin, 2,14, Frances, Williamson, 12,14,16, Luke, Burgess, 3, Fiona, Macfarlane, 5, Marie, Cooke, 4, Callan, Battley, 5,6, Claire, Rickard, 1,2,3,41Metro North Health Herston Infectious Disease Institute, Herston, QLD, Aus2The University of Queensland, School of Nursing, Midwifery and Social Work, St Lucia, QLD, Aus3Nursing Midwifery Research Centre, Royal Brisbane and Women’s Hospital, Herston, QLD, Aus4School of Nursing and Midwifery, Alliance for Vascular Access Teaching and Research, Griffith University, Nathan, QLD, Australia5Children’s Health Queensland Hospital and Health Service, Brisbane, QLD, Australia6Children’s Health Research Centre, The University of Queensland, Brisbane, QLD, Australia7School of Medicine and Dentistry, and Menzies Health Institute Queensland, Southport, QLD, Australia8Centre for Applied Health Economics, Griffith University, Brisbane, QLD, Australia9School of Public Health, The University of Queensland, Brisbane, QLD, Australia10Department of Emergency Medicine, Gold Coast University Hospital, Southport, QLD, Australia11Faculty of Health Sciences and Medicine, Bond University, Gold Coast, QLD, Australia12Emergency and Trauma Centre, Royal Brisbane and Women’s Hospital, Brisbane, QLD, Australia13School of Nursing, Midwifery & Social Science, Central Queensland University, Cairns, QLD, Australia14Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia15Department of Anaesthesia and Perioperative Medicine, Royal Brisbane and Women’s Hospital, Herston, QLD, Australia16Jamieson Trauma Institute, Herston, QLD, Australia
Introduction
Approximately half of patients requiring peripheral intravenous catheter (PIVC) insertion have difficult intravenous access (DIVA) requiring multiple insertion attempts. Ultrasound-guided PIVC insertion increases first-attempt success, but widespread implementation has not been evaluated.
Methods
Stepped wedge cluster randomised controlled trial to evaluate the implementation and effectiveness of a co-designed DIVA identification and escalation tool across three Queensland hospitals (12 clusters/wards). Hospital-based assessments, readiness surveys and key informant interviews were conducted during the trial. Outcome measures included patient outcomes (primary endpoint: first-time PIVC insertion success for both all and high-risk of DIVA patients; secondary: ultrasound use and time to insert), implementation outcomes (e.g., readiness for change) and service outcomes (e.g., cluster level blood stream infection rates).
Results
A total of 1,354 patients were enrolled (679 usual care [baseline], 675 DIVA intervention). Sustainability is ongoing (anticipated completion July 2023). Early analysis shows a non-significant change in first attempt PIVC insertion in high-risk DIVA patients (42% to 54%; odds ratio [OR] 1.59, 95% CI [confidence interval] 0.78, 3.22), all patients (61% to 65%; OR 1.22, 95%CI 0.86, 1.75), and use of ultrasound in high-risk DIVA patients (for first attempt; 43% to 57%; OR 2.05, 95%CI 0.90, 4.70). Average time to insertion improved for high-risk DIVAs (-0.55 hours, 95%CI -0.89 to 0.21, p=0.002). No blood stream infections were reported.
Conclusions
Preliminary findings indicate ultrasound use increases first-time PIVC insertion success in high-risk DIVA patients. However, achieving ultrasound adoption requires organisation wide implementation strategies to maximise the impact for all patients.
Biography
Jessica is a conjoint senior research fellow with Metro North Health, Herston Infectious Disease Institute and The University of Queensland School of Nursing Midwifery and Social Work. Jessica is interested in advances in infectious disease surveillance and tracking, using a combination of mature platforms and new electronic platforms. Jessica is leading the process evaluation of the DART 3 trial to determine factors which optimise the implementation of ultrasound guided PIVC insertion.